© Empagran
Cargill first brought its nutrition formulation expertise to Ecuador in 2015, when it partnered with shrimp-farming company Naturisa to build and operate a shrimp-feed manufacturing facility under the name Aquacargill del Ecuador.
“Since that time, the Ecuadorian shrimp farming industry has continued to grow, and there is a need to meet the increased demand for high-quality feed,” said Helene Ziv-Douki, president of Cargill’s aqua nutrition business, in a press release about the agreement.
Through this new joint venture with Skyvest, Cargill will expand its shrimp-feed production capabilities to own and operate the shrimp-feed production facility currently owned by Skyvest subsidiary Empagran, which is located in Guayaquil, Ecuador. The feed plant was built in 2018, currently has a production capacity of 156,000 tonnes and employs more than 200 people.
“Through this joint venture, Cargill will nearly double its production capacity, and we will improve our capacity to serve our customers and partners. We will invest in this facility and expand our offering of shrimp feeds under the Cargill’s Aquaxcel brand to meet increasing demand for feed among our customers,” said Angel Gomez, managing director of Cargill’s aqua nutrition business in northern Latin America.
“Our joint venture with Cargill has been a big success and a driver of growth for both organisations. We have established an excellent working relationship and we are excited to participate in this expansion to increase our production capacity of high-performance feed that will continue supporting the growth of the Ecuadorian shrimp industry,” said Francisco Sola, Naturisa president.
“We are excited that Cargill will bring its operational expertise and its deep knowledge of global supply chains and risk management to run this facility,” said Victor Ernesto Estrada Santistevan, owner of Skyvest. “The Cargill knowhow will improve feed quality, and their willingness to invest in the plant will bring more high-quality feed to the market”.
The transaction, which is subject to regulatory approvals, is expected to close in the coming months.
